Riskpilot← Back to searchSign inGet full accessekmedico AB
ABDissolvedOrg 5569266207FalunGeneral medical practice activities · NACE 8621Est. 20131 employees
Revenue 2024
SEK -3
+200% vs 2023
EBITDA margin
588700.0%
-18% vs 2023
Equity ratio
95.3%
Financial strength
Net profit 2024
SEK -17K
-550% vs 2023
| Revenue | SEK -3 | +200% |
| EBITDA | SEK -18K | -18% |
| Net profit | SEK -17K | -550% |
| Total assets | SEK 166K | -10% |
| Equity | SEK 158K | -10% |
| Employees | 1 | — |
Legal name
ekmedico AB
Org number
5569266207
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
21 mars 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Hälso- och sjukvård inom allmän medicin, utbildning och handledning inom hälso- och sjukvård samt handel och förvaltning av värdepapper.
Address
Falun
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 301 | 145 | 52 | −0 | −0 |
| Staff expenses | — | — | −22 | −0 | — |
| EBITDA | 88 | 36 | 24 | −15 | −18 |
| Depreciation & amort. | −0 | −0 | −17 | — | — |
| EBIT | 88 | 36 | 7 | −15 | −18 |
| Net financials | — | — | −0 | 0 | 0 |
| Profit before tax | 67 | 36 | 7 | 5 | −17 |
| Tax | −18 | −8 | −1 | −1 | — |
| Net profit | 49 | 28 | 5 | 4 | −17 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 231 | 204 | 199 | 183 | 166 |
| Equity | 138 | 166 | 171 | 175 | 158 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 72 | 18 | 8 | 8 | 8 |
| Total debt | 72 | 18 | 8 | 8 | 8 |
EBITDA margin
-1766100.0%
This company
15.8%
Market median
-11177948% vs market
20202024
Equity ratio
95.3%
This company
38.2%
Market median
+149% vs market
20202024
Return on equity
-11.0%
This company
18.4%
Market median
-160% vs market
20202024
Net profit margin
-1738400.0%
This company
8.1%
Market median
-21461828% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ekmedico AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | Deputy Board Member | 0 companies |
| Inger Margareta Dahle | Deputy Board Member | 0 companies |
| Karl-Erik Rasmus Ekmark | Board of Directors | 0 companies |
| Bengt Junior Niklas Nygårds | Deputy Board Member | 0 companies |
| Ulrika Margareta Ahlholm | Board of Directors | 0 companies |
| Eva Sara Ekmark Lewén | Deputy Board Member | 0 companies |